Healthcare - Biotechnology - NASDAQ - US
$ 41.96
-8.67 %
$ 2.72 B
Market Cap
-19.61
P/E
Price Target
Average
33.06%
Revenue Forecast
Estimate
10.72%
EBIT
Estimate
8.09%
Net Income
Estimate
--7.26%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Kymera Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for KYMR of $55.8 , with forecasts ranging from a low of $46 to a high of $65 .
KYMR Lowest Price Target
Wall Street Target
46 USD
9.63%
KYMR Average Price Target
Wall Street Target
55.8 USD
33.06%
KYMR Highest Price Target
Wall Street Target
65 USD
54.91%
REVENUE FORECAST
Revenue Forecast Chart KYMR
EBIT FORECAST
EBIT Forecast Chart KYMR
NET INCOME FORECAST
Net Income Chart KYMR